NF-κB activation stimulates the transcription of hepatocyte growth factor (HGF), which is a hepatocyte mitogen elevated in sera of patients with NAFLD, obesity, hypertension, and metabolic syndrome [15,16,17]. Here, NFKB1 is linked to obesity disorder.